Peripheral Vasculopathy Associated with Psychostimulant Treatment in Children with Attention-Deficit/Hyperactivity Disorder

被引:13
|
作者
Yu, Zheya Jenny [1 ]
Parker-Kotler, Caroline [2 ]
Tran, Kathleen [3 ]
Weller, Ronald A. [4 ]
Weller, Elizabeth B. [5 ]
机构
[1] Univ Penn Hlth Syst, Penn Hosp, Hall Mercer MH MR Ctr, Philadelphia, PA 19107 USA
[2] Greentree Pediat, Marlton, NJ 08053 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[4] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA
[5] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
关键词
Psychostimulants; Vasculopathy; METHYLPHENIDATE; METHAMPHETAMINE; PHENTERMINE; STROKE;
D O I
10.1007/s11920-010-0093-y
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Psychostimulants (methylphenidate and amphetamine salt) are the pharmacologic treatment of choice for children with attention-deficit/hyperactivity disorder. However, psychostimulants have been linked to a variety of vascular problems, including peripheral vasculopathy. This article describes four boys with attention-deficit/hyperactivity disorder who developed vasculopathy during treatment with psychostimulants.
引用
收藏
页码:111 / 115
页数:5
相关论文
共 50 条
  • [1] Peripheral Vasculopathy Associated with Psychostimulant Treatment in Children with Attention-Deficit/Hyperactivity Disorder
    Zheya Jenny Yu
    Caroline Parker-Kotler
    Kathleen Tran
    Ronald A. Weller
    Elizabeth B. Weller
    Current Psychiatry Reports, 2010, 12 : 111 - 115
  • [2] Developmental aspects of psychostimulant treatment in children and adolescents with attention-deficit/hyperactivity disorder
    Findling, RL
    Short, EJ
    Manos, MJ
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2001, 40 (12): : 1441 - 1447
  • [3] Attention-deficit hyperactivity disorder in Manitoba children: Medical diagnosis and psychostimulant treatment rates
    Brownell, MD
    Yogendran, MS
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2001, 46 (03): : 264 - 272
  • [4] Adherence to Psychostimulant Medication in Children with Attention-Deficit/Hyperactivity Disorder: The Role of Attitudes
    Hebert, Julien
    Polotskaia, Anna
    Joober, Ridha
    Grizenko, Natalie
    JOURNAL OF THE CANADIAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2013, 22 (04) : 317 - 323
  • [5] Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder -: The multimodal treatment study of children with attention-deficit/hyperactivity disorder
    Jensen, PS
    Arnold, LE
    Richters, JE
    Severe, JB
    Vereen, D
    Vitiello, B
    Schiller, E
    Hinshaw, SP
    Elliott, GR
    Conners, CK
    Wells, KC
    March, J
    Swanson, J
    Wigal, T
    Cantwell, DP
    Abikoff, HB
    Hechtman, L
    Greenhill, LL
    Newcorn, JH
    Pelham, WE
    Hoza, B
    Kraemer, HC
    ARCHIVES OF GENERAL PSYCHIATRY, 1999, 56 (12) : 1088 - 1096
  • [6] Multimodal treatment of attention-deficit hyperactivity disorder in children
    Jans, T.
    Kreiker, S.
    Warnke, A.
    NERVENARZT, 2008, 79 (07): : 791 - +
  • [7] Methylphenidate in the treatment of children with attention-deficit hyperactivity disorder
    Vitiello, B
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2001, 165 (11) : 1505 - 1506
  • [8] Multimodal Treatment of Attention-Deficit/Hyperactivity Disorder in Children
    Felt, Barbara T.
    Lumeng, Julie
    Christner, Jennifer
    AMERICAN FAMILY PHYSICIAN, 2009, 79 (08) : 640 - +
  • [9] TREATMENT ISSUES IN CHILDREN WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER
    GREENHILL, LL
    PSYCHIATRIC ANNALS, 1989, 19 (11) : 604 - 613
  • [10] Meta-Analysis: Reduced Risk of Anxiety with Psychostimulant Treatment in Children with Attention-Deficit/Hyperactivity Disorder
    Coughlin, Catherine G.
    Cohen, Stephanie C.
    Mulqueen, Jilian M.
    Ferracioli-Oda, Eduardo
    Stuckelman, Zachary D.
    Bloch, Michael H.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2015, 25 (08) : 611 - 617